HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Mitchell, A M Articles by Mortimer, R H Search for Related Content PubMed PubMed Citation Articles by Mitchell, A M Articles by Mortimer, R H

¹ Conjoint Endocrine Laboratory, Royal Brisbane and Women’s Hospital Research Foundation, Bancroft Centre, Brisbane, Queensland 4029, Australia
² Queensland Health Pathology Service, Royal Brisbane and Women’s Hospital, Brisbane, Queensland 4029, Australia
³ Department of Endocrinology, Royal Brisbane and Women’s Hospital, Brisbane, Queensland 4029, Australia
⁴ Department of Obstetrics and Gynaecology, University of Queensland, Brisbane, Queensland 4029, Australia

(Requests for offprints should be addressed to R H Mortimer, Royal Brisbane and Women’s Hospital, Base Hospitals, Herston, Queensland 4029, Australia; Email: Robin Mortimer{at}health.qld.gov.au)

Verapamil inhibits tri-iodothyronine (T₃) efflux from several cell types, suggesting the involvement of multidrug resistance-associated (MDR) proteins in T₃ transport. The direct involvement of P-glycoprotein (P-gp) has not, however, been investigated. We compared the transport of ¹²⁵I-T₃ in MDCKII cells that had been transfected with mdr1 cDNA (MDCKII-MDR) versus wild-type MDCKII cells (MDCKII), and examined the effect of conventional (verapamil and nitrendipine) and specific MDR inhibitors (VX 853 and VX 710) on ¹²⁵I-T₃ efflux. We confirmed by Western blotting the enhanced expression of P-gp in MDCKII-MDR cells. The calculated rate of ¹²⁵I-T₃ efflux from MDCKII-MDR cells (around 0.30/min) was increased twofold compared with MDCKII cells (around 0.15/min). Overall, cellular accumulation of ¹²⁵I-T₃ was reduced by 26% in MDCKII-MDR cells compared with MDCKII cells, probably reflecting enhanced export of T₃ from MDCKII-MDR cells rather than reduced cellular uptake, as P-gp typically exports substances from cells. Verapamil lowered the rate of ¹²⁵I-T₃ efflux from both MDCKII and MDCKII-MDR cells by 42% and 66% respectively, while nitrendipine reduced ¹²⁵I-T₃ efflux rate by 36% and 48% respectively, suggesting that both substances inhibited other cellular T₃ transporters in addition to P-gp. The specific MDR inhibitors VX 853 and VX 710 had no effect of ¹²⁵I-T₃ efflux rate from wild-type MDCKII cells but reduced ¹²⁵I-T₃ export in MDCKII-MDR cells by 50% and 53% respectively. These results have provided the first direct evidence that P-gp exports thyroid hormone from cells.

This article has been cited by other articles:

				X. Ding, K. Lichti, I. Kim, F. J. Gonzalez, and J. L. Staudinger Regulation of Constitutive Androstane Receptor and Its Target Genes by Fasting, cAMP, Hepatocyte Nuclear Factor {alpha}, and the Coactivator Peroxisome Proliferator-activated Receptor {gamma} Coactivator-1{alpha} J. Biol. Chem., September 8, 2006; 281(36): 26540 - 26551. [Abstract] [Full Text] [PDF]